Related Experiment Video
Updated: Jun 16, 2026

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
Published on: July 16, 2020
Epidemiology and clinical course of PFAPA syndrome in the pediatric population-single center study
Natalia Gołuchowska1, Agata Tomaszewska2,3, Aldona Ząber2
1Department of Pediatrics, Nephrology and Allergology, Military Institute of Medicine - National Research Institute, Szaserów 128, 04-141, Warsaw, Poland. goluchowskan@gmail.com.
Insights
Periodic Fever with Aphthous Stomatitis, Pharyngitis, and Adenitis (PFAPA) syndrome is common in children. This study characterizes PFAPA in Polish children, confirming effective treatments like prednisone and tonsillectomy.
Area of Science:
- Pediatrics
- Immunology
- Genetics
Background:
- PFAPA syndrome is the most common autoinflammatory disease in children, with an unknown cause.
- It presents as recurrent fever episodes with specific clinical signs.
Purpose of the Study:
- To characterize PFAPA syndrome in a large Polish pediatric cohort.
- To analyze clinical manifestations, treatment approaches, and laboratory findings.
Main Methods:
- Retrospective study of 47 children diagnosed with PFAPA syndrome.
- Data collected via structured questionnaires, including clinical, therapeutic, and laboratory data.
Main Results:
- Median age of 5 years, predominantly males (59.6%).
- Typical symptoms include fever (mean 5 days), cervical lymphadenopathy (91.5%), tonsillar exudates (85.1%), pharyngitis (74.5%), and oral aphthae (51.1%).
- Prednisone effective in 97.6%; tonsillectomy resolved symptoms in 83.3% of cases.
Conclusions:
- Confirms the clinical and epidemiological profile of PFAPA in children.
- Highlights the high efficacy of glucocorticoid therapy and tonsillectomy.
- Aims to reduce antibiotic overuse by better understanding PFAPA.
Objective:
PFAPA syndrome is the most common autoinflammatory disease of childhood, with an as yet unknown etiology. It is characterized by recurrent, periodic episodes of fever accompanied by specific clinical features. The aim of this study was to provide a detailed characterization of PFAPA syndrome in a large Polish pediatric cohort.
Methods:
We conducted a retrospective study based on data from 47 children with a confirmed diagnosis of PFAPA syndrome. Data were collected using structured questionnaires. Detailed analyses included clinical manifestations, therapeutic approaches, and laboratory findings.
Results:
The median age of the study population was 5 years, with a predominance of males (59.6%). In 91.5% of patients, the first episode of fever occurred before the age of 5 years. Febrile episodes lasted a mean of 5 days, with a median inter-episode interval of 3 weeks. The key clinical manifestations included cervical lymphadenopathy (91.5%), tonsillar exudates (85.1%), pharyngitis (74.5%), and oral aphthae (51.1%). During afebrile intervals, 87.2% of patients were free of symptoms. Laboratory evaluation showed elevated inflammatory markers, with a median C-reactive protein level of 6.9 mg/d (in the 9 patients with available laboratory data), a median erythrocyte sedimentation rate of 35.0 mm/h, and a mean neutrophil count of 11.8 × 10^3/µL. Prednisone treatment was effective in 97.6% of cases. Tonsillectomy was performed in 25.5% of children and resulted in complete resolution of febrile episodes in 83.3% of them.
Conclusions:
This study confirms the established epidemiologic and clinical profile of PFAPA syndrome in the pediatric population, highlighting its characteristic manifestations and the high effectiveness of glucocorticoid therapy and tonsillectomy. The findings may contribute to consolidating current knowledge about PFAPA and to reducing the inappropriate use of antibiotics.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Acute Pyelonephritis II: Diagnostic Studies and Management
Pharmacokinetics in Pediatric Patients: Drug Distribution
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Pharmacokinetics in Pediatric Patients: Drug Excretion